Prognostic significance of albuminuria in patients with renal cell cancer

Journal of Urology

Volumn 170, Issue 4 I, 2003, Pages 1135-1137

  Vaglio, Augusto ^a   Buzio, Luca ^a   Cravedi, Paolo ^a   Pavone, Laura ^a   Garini, Giovanni ^a   Buzio, Carlo ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Albuminuria; Carcinoma, renal cell; Kidney; Neoplasm staging

Indexed keywords

CREATININE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT INTERLEUKIN 12;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; TREATMENT OUTCOME; URINARY EXCRETION;

EID: 0041691161     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000085984.90991.9a     Document Type: Article

References (18)

1. Sawyer, N., Wadsworth, J., Wijnen, M. and Gabriel, R.: Prevalence, concentration and prognostic importance of proteinuria in patients with malignancies. Br Med J, 296: 1295, 1988
2. Pedersen, L. M. and Milman, N.: Microalbuminuria in patients with lung cancer. Eur J Cancer, 34: 76, 1998
3. Pedersen, L. M. and Sorensen, P. G.: Increased urinary albumin excretion rate in breast cancer patients. Acta Oncol, 39: 145, 2000
4. Roumen, R. M. and Wijnen, M. H.: Proteinuria: a frequent paraneoplastic phenomenon in colorectal cancer? Eur J Cancer, 34: 206, 1998
5. Pedersen, L. M. and Sorensen, P. G.: Clinical significance of urinary albumin excretion in patients with non-Hodgkin's lymphoma. Br J Haematol, 107: 889, 1999
6. Hemmingsen, L. and Skaarup, P.: Urinary excretion of ten plasma proteins in patients with renal carcinoma. Scand J Urol Nephrol, 11: 41, 1977
7. Buzio, C., Andrulli, S., Santi, R., Pavone, L., Passalacqua, R., Potenzoni, D. et al: Long-term immunotherapy with low-dose interleukin-2 and interferon-alpha in the treatment of patients with advanced renal cell carcinoma. Cancer, 92: 2286, 2001
8. Mercatello, A., Hadj-Aissa, A., Negrier, S., Allaouchiche, B., Coronel, B., Tognet, E. et al: Acute renal failure with preserved renal plasma flow induced by cancer immunotherapy. Kidney Int, 40: 309, 1991
9. Sobin, L. H. and Wittekind, Ch.: TNM Classification of Malignant Tumours, 5th ed. New York: Wiley-Liss, pp. 180-182, 1997
10. Fuhrman, S. A., Lasky, L. C. and Limas, C.: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol, 6: 655; 1982
11. Concato, J., Feinstein, A. R. and Holford, T. R.: The risk of determining risk with multivariable models. Ann Intern Med, 118: 201, 1993
12. Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T. et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol, 5: 649, 1982
13. Ronco, P. M.: Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int, 56: 355, 1999
14. Alpers, C. E. and Cotran, R. S.: Neoplasia and glomerular injury. Kidney Int, 30: 465, 1986
15. Davison, A. M. and Thomson, D.: Malignancy-associated glomerular disease. In: Oxford Textbook of Clinical Nephrology. Edited by S. Cameron, A. M. Davison, J.-P. Grünfeld, D. Kerr and E. Ritz. New York: Oxford University Press, vol. 1, chapt. 13, pp. 475-486, 1992
16. Fossa, S. D., Kramar, A. and Droz, J. P.: Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alpha. Eur J Cancer, 30A: 1310, 1994
17. Beaufils, H., Patte, R., Aubert, P., Camey, M., Kuss, R., Barbagelatta, M. et al: Renal immunopathology in renal cell carcinoma. Virchows Arch A Pathol Anat Histopathol, 404: 87, 1984
18. Quesada, J. R., Talpaz, M., Rios, A., Kurzrock, R. and Gutterman, J. U.: Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol, 4: 234, 1986